1. Home
  2. COEP vs ENZ Comparison

COEP vs ENZ Comparison

Compare COEP & ENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
    SELLHOLDBUYas of 2 days ago
  • ENZ
    SELLHOLDBUYas of 2 days ago
  • Stock Information
  • Founded
  • COEP 2017
  • ENZ 1976
  • Country
  • COEP United States
  • ENZ United States
  • Employees
  • COEP N/A
  • ENZ N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • ENZ Medical Specialities
  • Sector
  • COEP Health Care
  • ENZ Health Care
  • Exchange
  • COEP Nasdaq
  • ENZ Nasdaq
  • Market Cap
  • COEP 30.5M
  • ENZ 34.2M
  • IPO Year
  • COEP N/A
  • ENZ N/A
  • Fundamental
  • Price
  • COEP $9.67
  • ENZ $0.29
  • Analyst Decision
  • COEP
  • ENZ
  • Analyst Count
  • COEP 0
  • ENZ 0
  • Target Price
  • COEP N/A
  • ENZ N/A
  • AVG Volume (30 Days)
  • COEP 44.6K
  • ENZ 229.0K
  • Earning Date
  • COEP 05-09-2025
  • ENZ 03-17-2025
  • Dividend Yield
  • COEP N/A
  • ENZ 34.48%
  • EPS Growth
  • COEP N/A
  • ENZ N/A
  • EPS
  • COEP N/A
  • ENZ N/A
  • Revenue
  • COEP N/A
  • ENZ $29,094,000.00
  • Revenue This Year
  • COEP N/A
  • ENZ N/A
  • Revenue Next Year
  • COEP N/A
  • ENZ N/A
  • P/E Ratio
  • COEP N/A
  • ENZ N/A
  • Revenue Growth
  • COEP N/A
  • ENZ N/A
  • 52 Week Low
  • COEP $2.31
  • ENZ $0.26
  • 52 Week High
  • COEP $13.70
  • ENZ $1.30
  • Technical
  • Relative Strength Index (RSI)
  • COEP 47.64
  • ENZ 17.51
  • Support Level
  • COEP $9.01
  • ENZ $0.45
  • Resistance Level
  • COEP $9.99
  • ENZ $0.50
  • Average True Range (ATR)
  • COEP 0.63
  • ENZ 0.05
  • MACD
  • COEP 0.03
  • ENZ -0.01
  • Stochastic Oscillator
  • COEP 67.62
  • ENZ 13.67

Stock Price Comparison Chart: COEP vs ENZ

COEP
ENZ
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025April01234567891011121314COEP VS ENZ

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About ENZ Enzo Biochem Inc. ($0.01 Par Value)

Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins.

Share on Social Networks:

By browsing this website, you accept our Privacy Policy & Terms of Use